Provenance Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History
Provenance Wealth Advisors, LLC
- $774 Billion
- Q3 2025
A detailed history of Provenance Wealth Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Provenance Wealth Advisors, LLC holds 2,614 shares of GILD stock, worth $324,371. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,614
Previous 2,639
0.95%
Holding current value
$324,371
Previous $296 Million
1.88%
% of portfolio
0.04%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,366Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...